Basics Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals. IPO Date: December 31, 1981 Sector: Healthcare Industry: Pharma Market Cap: $95.42B Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 0.92% Avg Daily Range (30 D): $0.64 | 1.34% Avg Daily Range (90 D): $0.77 | 1.42% Institutional Daily Volume Avg Daily Volume: 9.37M Avg Daily Volume (30 D): 12.74M Avg Daily Volume (90 D): 11.02M Trade Size Avg Trade Size (Sh.): 183 Avg Trade Size (Sh.) (30 D): 106 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 122,722 Avg Inst. Trade: $4.93M Avg Inst. Trade (30 D): $6.14M Avg Inst. Trade (90 D): $6.25M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 22 Market Closing Trades Avg Closing Trade: $57.65M Avg Closing Trade (30 D): $121.81M Avg Closing Trade (90 D): $121.51M Avg Closing Volume: 1.07M         News Jun 2, 2025 @ 2:14 PM Bristol Myers Inks $11 Billion Licensing Pact With... Source: Vandana Singh May 29, 2025 @ 5:16 PM Bispecific Antibody Drug Conjugates Clinical Trial... Source: Kuick Research May 27, 2025 @ 1:00 PM Rapid Micro Biosystems Announces Appointment of Dr... Source: Globe Newswire May 27, 2025 @ 11:00 AM GlycoEra AG Raises $130 Million to Advance Novel P... Source: N/A May 20, 2025 @ 9:00 AM Tubulis Achieves Key Milestone in BMS Strategic Li... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $2.69 $1.21 $.04 Diluted EPS $2.68 $1.2 $.04 Revenue $ 47.64B $ 11.2B $ 12.34B Gross Profit $ 33.57B $ 8.17B $ 7.53B Net Income / Loss $ 5.44B $ 2.46B $ 76M Operating Income / Loss $ 6.11B $ 2.97B $ 175M Cost of Revenue $ 14.07B $ 3.03B $ 4.81B Net Cash Flow $ 1.54B $ 528M $ 2.45B PE Ratio 18.19